Long-acting growth hormone: an updated Growth Hormone Research Society consensus statement
Methodological detailsinternational workshop
- International workshop
Recommendations
As issued by the authors
Careful patient selection and counselling
Product-specific dosing
Insulin-like growth factor-I (IGF-I) monitoring
Well-resourced registries are essential for addressing knowledge gaps (transition care, long-term efficacy, adherence, safety in cancer survivors)
Original publication
Long-acting growth hormone: an updated Growth Hormone Research Society consensus statement. Eur J Endocrinol. Published 1 September 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →